JPWO2020033272A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020033272A5 JPWO2020033272A5 JP2021506562A JP2021506562A JPWO2020033272A5 JP WO2020033272 A5 JPWO2020033272 A5 JP WO2020033272A5 JP 2021506562 A JP2021506562 A JP 2021506562A JP 2021506562 A JP2021506562 A JP 2021506562A JP WO2020033272 A5 JPWO2020033272 A5 JP WO2020033272A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- hapten
- car
- apc
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024108743A JP2024138364A (ja) | 2018-08-06 | 2024-07-05 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862714928P | 2018-08-06 | 2018-08-06 | |
| US62/714,928 | 2018-08-06 | ||
| PCT/US2019/044981 WO2020033272A1 (en) | 2018-08-06 | 2019-08-02 | Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024108743A Division JP2024138364A (ja) | 2018-08-06 | 2024-07-05 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021532818A JP2021532818A (ja) | 2021-12-02 |
| JPWO2020033272A5 true JPWO2020033272A5 (https=) | 2022-08-09 |
| JP2021532818A5 JP2021532818A5 (https=) | 2022-08-09 |
Family
ID=69415147
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506562A Pending JP2021532818A (ja) | 2018-08-06 | 2019-08-02 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
| JP2024108743A Pending JP2024138364A (ja) | 2018-08-06 | 2024-07-05 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024108743A Pending JP2024138364A (ja) | 2018-08-06 | 2024-07-05 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210317407A1 (https=) |
| EP (1) | EP3833363A4 (https=) |
| JP (2) | JP2021532818A (https=) |
| KR (1) | KR20210074274A (https=) |
| CN (1) | CN112789051A (https=) |
| AU (1) | AU2019319674A1 (https=) |
| CA (1) | CA3108778A1 (https=) |
| WO (1) | WO2020033272A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2934532B1 (en) | 2012-12-20 | 2019-10-23 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| CA2945320A1 (en) | 2014-04-10 | 2015-10-15 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Drug regulated transgene expression |
| EP4400516A1 (en) | 2014-12-15 | 2024-07-17 | The Regents of the University of California | Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20 |
| EP3234120B1 (en) | 2014-12-15 | 2025-09-03 | The Regents of the University of California | Cytotoxic molecules responsive to intracellular ligands for selective t cell mediated killing |
| DK3368571T5 (da) | 2015-10-30 | 2024-09-30 | Univ California | Transformerende, vækstfaktor-beta-responsive polypeptider og fremgangsmåder til anvendelse deraf |
| JP7282521B2 (ja) | 2016-04-08 | 2023-05-29 | パーデュー・リサーチ・ファウンデイション | Ｃａｒ ｔ細胞療法のための方法および組成物 |
| CN110612119B (zh) | 2017-02-07 | 2024-10-29 | 西雅图儿童医院（Dba西雅图儿童研究所） | 磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂 |
| JP7178355B2 (ja) | 2017-02-28 | 2022-11-25 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞療法のための組成物および方法 |
| JP7549303B2 (ja) | 2018-01-22 | 2024-09-11 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞の使用方法 |
| SG11202007426XA (en) * | 2018-02-06 | 2020-09-29 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors |
| CN112105382A (zh) | 2018-02-23 | 2020-12-18 | 恩多塞特公司 | 用于car t细胞疗法的顺序方法 |
| CN112262214A (zh) | 2018-04-12 | 2021-01-22 | 优莫佳生物制药股份有限公司 | 病毒载体及包装细胞系 |
| AU2021217003A1 (en) | 2020-02-04 | 2022-09-15 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Anti-dinitrophenol chimeric antigen receptors |
| IL295074A (en) * | 2020-02-04 | 2022-09-01 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Methods and compositions for stimulation of t cells with a chimeric receptor receptor by hapten-labeled cells |
| IL296511A (en) | 2020-03-20 | 2022-11-01 | Lyell Immunopharma Inc | Novel recombinant cell surface markers |
| US20230113157A1 (en) * | 2020-05-06 | 2023-04-13 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Compositions and methods for t cell engineering |
| CN111735952B (zh) * | 2020-06-04 | 2023-07-11 | 北京勤邦科技股份有限公司 | 一种检测六氯苯的试纸条及方法 |
| CN115803038A (zh) * | 2020-06-08 | 2023-03-14 | 西雅图儿童医院（Dba西雅图儿童研究所） | 抗cd171嵌合抗原受体 |
| AU2022227686A1 (en) | 2021-02-25 | 2023-07-27 | Lyell Immunopharma, Inc. | Ror1 targeting chimeric antigen receptor |
| CN114019166B (zh) * | 2021-09-27 | 2024-02-27 | 浙江省食品药品检验研究院 | 一种检测龙葵素的试纸条及其应用 |
| AU2022384253A1 (en) * | 2021-11-10 | 2024-05-30 | Outpace Bio, Inc. | Chimeric antigen receptors |
| CN119775406B (zh) * | 2025-01-22 | 2025-11-25 | 北京赛科希德科技股份有限公司 | 纤溶酶降解产物d-二聚体抗体及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004113062A (ja) * | 2002-09-25 | 2004-04-15 | Teruyuki Nagamune | キメラ受容体を有する動物細胞とその利用 |
| WO2016168769A1 (en) * | 2015-04-15 | 2016-10-20 | The California Institute For Biomedical Research | Chimeric receptor t cell switches for her2 |
| CN115404196A (zh) * | 2016-07-13 | 2022-11-29 | 哈佛学院院长等 | 抗原呈递细胞模拟支架及其制备和使用方法 |
| US11590214B2 (en) * | 2016-12-21 | 2023-02-28 | Danmarks Tekniskte Universitet | Antigen presenting scaffolds for immune-cell manipulation |
| WO2019060425A1 (en) * | 2017-09-19 | 2019-03-28 | Massachusetts Institute Of Technology | COMPOSITIONS FOR CHIMERIC ANTIGENIC RECEPTOR T CELL THERAPY AND USES THEREOF |
-
2019
- 2019-08-02 KR KR1020217006444A patent/KR20210074274A/ko active Pending
- 2019-08-02 US US17/265,484 patent/US20210317407A1/en active Pending
- 2019-08-02 CA CA3108778A patent/CA3108778A1/en active Pending
- 2019-08-02 CN CN201980065406.9A patent/CN112789051A/zh active Pending
- 2019-08-02 EP EP19846044.6A patent/EP3833363A4/en active Pending
- 2019-08-02 AU AU2019319674A patent/AU2019319674A1/en active Pending
- 2019-08-02 WO PCT/US2019/044981 patent/WO2020033272A1/en not_active Ceased
- 2019-08-02 JP JP2021506562A patent/JP2021532818A/ja active Pending
-
2024
- 2024-07-05 JP JP2024108743A patent/JP2024138364A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532818A5 (https=) | ||
| JPWO2020033272A5 (https=) | ||
| US12371663B2 (en) | Engineered γδ T-cells | |
| AU2019204921B2 (en) | Chimeric Antigen Receptor (CAR) with Antigen Binding Domains to the T Cell Receptor Beta Constant Region. | |
| JP2025023921A (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| CN111936518A (zh) | 对fl-ple标记的肿瘤表现出最佳的t细胞功能的荧光素特异性car | |
| JP2006506954A (ja) | Ｔｃｒ及びｔｉｒｃ７に結合する新規な抗体、並びに治療及び診断におけるその使用 | |
| CN115397440A (zh) | 用半抗原标记细胞刺激嵌合抗原受体t细胞的方法和组合物 | |
| US11885807B2 (en) | Method for depleting malignant T-cells | |
| AU2020398623A1 (en) | Methods for expanding γδ T-cell populations with multivalent agents and compositions thereof | |
| TW202146438A (zh) | 經工程化之t細胞受體及其使用方法 | |
| WO2019099744A1 (en) | METHODS FOR SELECTIVE EXPANSION OF δ3 γδ T-CELL POPULATIONS AND COMPOSITIONS THEREOF | |
| JPWO2021158534A5 (https=) | ||
| JPWO2021158523A5 (https=) | ||
| JPWO2022099100A5 (https=) | ||
| HK40109798A (zh) | 制导和导航控制蛋白及其制备和使用方法 | |
| HK40097671A (zh) | 制导和导航控制蛋白及其制备和使用方法 | |
| HK40097672A (zh) | 制导和导航控制蛋白及其制备和使用方法 | |
| CN111876381A (zh) | 一种t细胞模型及其在体外人源pd-1抗体药效评价中的应用 | |
| NZ761844B2 (en) | Conjugated antibody with antigen binding domains to the t cell receptor beta constant region | |
| HK1242585A1 (en) | Engineered gamma delta t-cells | |
| HK1242585B (en) | Engineered gamma delta t-cells |